WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018062728) INJECTION COMPOSITION CONTAINING CROSS-LINKED HYALURONIC ACID
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/062728    International Application No.:    PCT/KR2017/010082
Publication Date: 05.04.2018 International Filing Date: 14.09.2017
IPC:
A61L 27/58 (2006.01), A61L 27/20 (2006.01), A61K 9/00 (2006.01)
Applicants: AMOREPACIFIC CORPORATION [KR/KR]; 100, Hangang-daero Yongsan-gu Seoul 04386 (KR)
Inventors: KWON, Min Jung; (KR).
AH, Young Chang; (KR).
KIM, Hyuk; (KR).
HONG, Sung Woo; (KR).
PARK, Won Seok; (KR)
Agent: KIM, Sung Ho; (KR).
PARK, Hyung-Dal; (KR).
KIM, Byeong Pil; (KR)
Priority Data:
10-2016-0124999 28.09.2016 KR
Title (EN) INJECTION COMPOSITION CONTAINING CROSS-LINKED HYALURONIC ACID
(FR) COMPOSITION POUR INJECTION CONTENANT DE L’ACIDE HYALURONIQUE RÉTICULÉ
(KO) 가교 히알루론산을 포함하는 주사용 조성물
Abstract: front page image
(EN)The present invention relates to an injection composition containing cross-linked hyaluronic acid and, more specifically, to an injection composition containing: cross-linked hyaluronic acid having a concentration of 10 to 50 mg/ml; and chondroitin sulfate having a concentration of 10 to 50 mg/ml. The injection composition according to the present invention includes cross-linked hyaluronic acid and chondroitin sulfate corresponding to specific ranges, thereby showing improved viscoelastic flow characteristics so as to be usable as an injection and enabling application for various uses in the fields of beauty and medicine.
(FR)La présente invention concerne une composition pour injection contenant de l’acide hyaluronique réticulé et, plus spécifiquement, une composition pour injection contenant : de l’acide hyaluronique réticulé ayant une concentration de 10 à 50 mg/ml ; et du sulfate de chondroïtine ayant une concentration de 10 à 50 mg/ml. La composition pour injection selon la présente invention comprend de l’acide hyaluronique réticulé et du sulfate de chondroïtine correspondant à des plages spécifiques, de façon à présenter des caractéristiques d’écoulement viscoélastique améliorées de façon à pouvoir être utilisées en tant qu’injectable et permettre une application pour diverses utilisations dans les domaines de la beauté et de la médecine.
(KO)본 발명은 가교 히알루론산을 포함하는 주사용 조성물에 관한 것으로, 보다 상세하게는 농도가 10 내지 50 ㎎/㎖인 가교 히알루론산; 및 농도가 10 내지 50 ㎎/㎖인 콘드로이틴설페이트를 포함하는 주사용 조성물에 관한 것이다. 본 발명에 따른 주사용 조성물은 특정 범위에 해당하는 가교 히알루론산과 콘드로이틴설페이트을 포함함으로써 개선된 점탄성적 유동 특성을 나타내어 주사제로서 사용이 가능하며 미용 및 의학 분야에서 다양한 용도로의 적용을 가능케 한다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)